Search Results

• • 633 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Cisplatin induced paroxysmal supraventricular tachycardia

  Authors:Waseem Raja, M. Mir, Imtiyaz Dar, Muzamil Banday, and Irfan AhmadFrom:Indian Journal of Medical and Paediatric Oncology (Vol. 34, Issue 4) Peer-Reviewed

  October-December 20131,053 words Article 1370LByline: Waseem. Raja, M. Mir, Imtiyaz. Dar, Muzamil. Banday, Irfan. Ahmad Cisplatin or cis-diamminedichloroplatinum (CDDP) is the first member of a class of platinum-containing anti-cancer drugs that act by binding...

• Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center

  Authors:V. Patil, S. Chakraborty, P. Shenoy, A. Manuprasad, T. Sajith Babu, T. Shivkumar, et al.From:Indian Journal of Cancer (Vol. 51, Issue 1) Peer-Reviewed

  January-March 20143,305 words Report 1530LByline: V. Patil, S. Chakraborty, P. Shenoy, A. Manuprasad, T. Sajith Babu, T. Shivkumar, S. Babu, A. Bhatterjee, S. Balasubramanian Background: Recent studies indicate neoadjuvant chemotherapy (NACT) can result in...

• Genetic variation in Otos is associated with cisplatin-induced ototoxicity

  Authors:Timothy F Spracklen, Heather Whitehorn, Anna Alvera Vorster, Lebogang Ramma, Sameera Dalvie, and Rajkumar S RamesarFrom:Pharmacogenomics (Vol. 15, Issue 13) Peer-Reviewed

  Oct. 20146,242 words Report 1600LAuthor(s): Timothy F Spracklen aff1 , Heather Whitehorn aff1 , Anna Alvera Vorster aff1 , Lebogang Ramma aff2 , Sameera Dalvie aff3 , Rajkumar S Ramesar [*] aff1 Keywords: cisplatin; hearing loss; Otos ;...

• Protective effect of Artemisia asiatica (Pamp.) Nakai ex Kitam ethanol extract against cisplatin-induced apoptosis of human HaCaT keratinocytes: involvement of NF-kappa B- and Bcl-2-controlled mitochondrial signaling

  Authors:Jae Won Chang, Hye Sook Hwang, Yeon Soo Kim, Haeng Jun Kim, Yoo Seob Shin, Tatsanachat Jittreetat, et al.From:Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Vol. 22, Issue 6) Peer-Reviewed

  June 15, 20154,673 words Report 1440LABSTRACT Background: Oral mucositis is a common adverse effect of antineoplastic chemotherapy limiting sufficient dose of chemoregimen. Numerous attempts to mitigate chemotherapy-induced oral mucositis have failed to...

• Combined therapeutic effect and molecular mechanisms of metformin and cisplatin in human lung cancer xenografts in nude mice

  Authors:Yu-Qin Chen and Gang ChenFrom:Journal of Cancer Research and Therapeutics (Vol. 11, Issue 2) Peer-Reviewed

  April-June 20154,430 words Report 1580LByline: Yu-Qin. Chen, Gang. Chen Objective: This work was aimed at studying the inhibitory activity of metformin combined with the commonly used chemotherapy drug cisplatin in human lung cancer xenografts in nude...

• Cisplatin: arterial occlusion leading to gangrene: case report

  From:Reactions Weekly (Issue 1336)

  Jan. 29, 2011263 words Brief article, Case ... 1060L[S] A 50-year-old man developed arterial occlusion leading to gangrene of the toe during cisplatin-based chemotherapy for testicular cancer. The man, who was a chronic smoker, began an etoposide-cisplatin...

• Cisplatin/various drugs interaction: renal impairment: case report

  From:Reactions Weekly (Issue 1283)

  Jan. 9, 2010189 words Brief article, Case ... [X] [S] A 63-year-old man with hypertension and type 2 diabetes mellitus started treatment with cisplatin [dosage not stated] and gemcitabine for high-grade urethral cancer. He was also started on...

• Cisplatin/epirubicin: hepatitis reactivation and fatal liver failure: case report

  From:Reactions Weekly (Issue 1313)

  Aug. 7, 2010327 words Brief article, Case ... 1040L[S] A 51-year-old man developed hepatitis reactivation after receiving transarterial chemotherapy with epirubicin and cisplatin; he subsequently died from liver failure. The man had hepatitis B virus (HBV)-related...

• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

  From:British Medical Journal (Vol. 311, Issue 7010) Peer-Reviewed

  Oct. 7, 19957,804 words Article Chemotherapy may somewhat prolong survival among patients with non-small cell lung cancer, a cancer with low survival chances. Most lung cancers are of the non-small cell type. Researchers analyzed the effect of...

• Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck

  Authors:Eva Henriksson, Elisabeth Kjellen, Bo Baldetorp, Par-Ola Bendahl, Ake Borg, Eva Brun, et al.From:Journal of Experimental & Clinical Cancer Research (Vol. 28) Peer-Reviewed

  Feb. 13, 20095,466 words Report Authors: Eva Henriksson (corresponding author) [1]; Elisabeth Kjellén [2]; Bo Baldetorp [2]; Pär-Ola Bendahl [2]; Åke Borg [2]; Eva Brun [2]; Fredrik Mertens [3]; Tomas Ohlsson [4]; Karin Rennstam [2]; Johan Wennerberg...

• Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin

  Authors:Cristina Federici, Francesco Petrucci, Stefano Caimi, Albino Cesolini, Mariantonia Logozzi, Martina Borghi, et al.From:PLoS ONE (Vol. 9, Issue 2) Peer-Reviewed

  Feb. 6, 20148,017 words Article 1540LAuthor(s): Cristina Federici 1, Francesco Petrucci 2, Stefano Caimi 2, Albino Cesolini 3, Mariantonia Logozzi 1, Martina Borghi 1, Sonia D'Ilio 4, Luana Lugini 1, Nicola Violante 2, Tommaso Azzarito 1, Costanza Majorani...

• Cachexia induces head and neck changes in locally advanced oropharyngeal carcinoma during definitive cisplatin and image-guided volumetric-modulated arc radiation therapy

  Authors:R. Mazzola, F. Ricchetti, A. Florentino, G. Di Paola, S. Fersino, N. Giaj Levra, et al.From:European Journal of Clinical Nutrition (Vol. 70, Issue 6) Peer-Reviewed

  June 20164,082 words Report 1630LBACKGROUND/OBJECTIVES: Cancer cachexia is a syndrome characterized by weight loss (WL) and sarcopenia. Aim of the study was to assess the impact of cachexia on head and neck changes during definitive cisplatin and...

• Cellular Preoxygenation Partially Attenuates the Antitumoral Effect of Cisplatin despite Highly Protective Effects on Renal Epithelial Cells

  Authors:Bahram Rasoulian, Ayat Kaeidi, Maryam Rezaei, and Zahra HajializadehFrom:Oxidative Medicine and Cellular Longevity (Vol. 2017) Peer-Reviewed

  Annual 20175,649 words Article 1420LOur previous in vitro studies demonstrated that oxygen pretreatment significantly protects human embryonic renal tubular cell against acute cisplatin- (CP-) induced cytotoxicity. The present study was designed to...

• Evaluation of the Protective Effect of Olive Leaf Extract on Cisplatin-Induced Testicular Damage in Rats.

  Authors:Rafa S. Almeer and Ahmed E. Abdel MoneimFrom:Oxidative Medicine and Cellular Longevity (Vol. 2018) Peer-Reviewed

  Annual 20185,693 words Article 1350LIn the present investigation, the effect of olive leaf extract (OLE) on testicular damage induced in rats by an intraperitoneal injection of cisplatin (cis-diamminedichloroplatinum (CDDP)) at a dose of 5 mg/kg was...

• Protective Effect of Silybum marianum and Nigella sativa Oil Extracts against Cisplatin Induced Nephrotoxicity in Mice.

  Authors:A. Ashraf, F. Hassan, S. Batool, M. Nadeem, M. Irshad, A. Siddique, et al.From:Current Topics in Nutraceutical Research (Vol. 18, Issue 2) Peer-Reviewed

  May 20203,321 words Article 1470LThe objective of present study was to analyze and compare the nephroprotective effects of petroleum ether extracts of seeds of Nigella sativa and Silybum marianum in Swiss albino mice. Petroleum ether extracts of seeds...

• Cisplatin loaded hyaluronic acid modified Ti[O.sub.2] nanoparticles for neoadjuvant chemotherapy of ovarian cancer

  Authors:Enling Liu, Yuxiu Zhou, Zheng Liu, Jun Li, Donghong Zhang, Junchen Chen, et al.From:Journal of NanomaterialsPeer-Reviewed

  Annual 20154,601 words Article 1410LNovel tumor-targeting titanium dioxide (Ti[O.sub.2]) nanoparticles modified with hyaluronic acid (HA) were developed to explore the feasibility of exploiting the pH-responsive drug release property of Ti[O.sub.2] and...

• Hemin attenuates cisplatin-induced acute renal injury in male rats

  Authors:Mohamed A. Al- Kahtani, Ashraf M. Abdel-Moneim, Omar M. Elmenshawy, and Mohamed A. El- KershFrom:Oxidative Medicine and Cellular Longevity (Vol. 2014) Peer-Reviewed

  Annual 20144,811 words Report 1350LBackground. The aim of this study is to investigate the protective effects of hemin (the heme oxygenase-1 [OH-1] inducer) against nephrotoxic effects induced by cisplatin [cis- diamminedichloroplatinum II (CP)] in male...

• Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity.

  Authors:Ya-Hong Liu, Kui Li, and Hong-Qi TianFrom:Oxidative Medicine and Cellular LongevityPeer-Reviewed

  May 31, 20206,787 words Article 1290LAcute renal injury has an incidence of 25%-30% in patients with tumors who are treated with cisplatin and in patients for whom no specific drugs are available for treatment. Amifostine is the only FDA-approved...

• A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients

  Authors:Hark Kyun Kim, Il Ju Choi, Chan Gyoo Kim, Hee Sung Kim, Akira Oshima, Aleksandra Michalowski, et al.From:PLoS ONE (Vol. 6, Issue 2) Peer-Reviewed

  Feb. 18, 20117,738 words Clinical report 1680LBackground We initiated a prospective trial to identify transcriptional alterations associated with acquired chemotherapy resistance from pre- and post-biopsy samples from the same patient and uncover potential...

• Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer

  Authors:Haiyan Ge, Songshi Ni, Xingan Wang, Nuo Xu, Ying Liu, Xun Wang, et al.From:PLoS ONE (Vol. 7, Issue 12) Peer-Reviewed

  Dec. 18, 20128,486 words Article 1410LIntroduction Dexamethasone (DEX) co-treatment has proved beneficial in NSCLC patients, improving clinical symptoms by the reduction of side effects after chemotherapy. However, recent studies have shown that DEX...